Abstract:Abstract Motivation Combination therapy has shown to improve therapeutic efficacy while reducing side effects. Importantly, it has become an indispensable strategy to overcome resistance in antibiotics, antimicrobials and anticancer drugs. Facing enormous chemical space and unclear design principles for small-molecule combinations, computational drug-combination design has not seen generative models to meet its potential to accelerate resistance-overcoming drug combination discovery. Results We have developed the first deep generative model for drug combination design, by jointly embedding graph-structured domain knowledge and iteratively training a reinforcement learning-based chemical graph-set designer. First, we have developed hierarchical variational graph auto-encoders trained end-to-end to jointly embed gene–gene, gene–disease and disease–disease networks. Novel attentional pooling is introduced here for learning disease representations from associated genes’ representations. Second, targeting diseases in learned representations, we have recast the drug-combination design problem as graph-set generation and developed a deep learning-based model with novel rewards. Specifically, besides chemical validity rewards, we have introduced novel generative adversarial award, being generalized sliced Wasserstein, for chemically diverse molecules with distributions similar to known drugs. We have also designed a network principle-based reward for disease-specific drug combinations. Numerical results indicate that, compared to state-of-the-art graph embedding methods, hierarchical variational graph auto-encoder learns more informative and generalizable disease representations. Results also show that the deep generative models generate drug combinations following the principle across diseases. Case studies on four diseases show that network-principled drug combinations tend to have low toxicity. The generated drug combinations collectively cover the disease module similar to FDA-approved drug combinations and could potentially suggest novel systems pharmacology strategies. Our method allows for examining and following network-based principle or hypothesis to efficiently generate disease-specific drug combinations in a vast chemical combinatorial space. Availability and implementation https://github.com/Shen-Lab/Drug-Combo-Generator. Supplementary information Supplementary data are available at Bioinformatics online.

Graph neural networks for conditional de novo drug design

Graph Neural Networks for Drug Discovery: An Integrated Decision Support Pipeline

Multi-Objective De Novo Drug Design with Conditional Graph Generative Model

Graph-based generative models for de Novo drug design

Molecular generative Graph Neural Networks for Drug Discovery

Graph networks for molecular design

Graph Neural Networks for COVID-19 Drug Discovery

Molecule Generation for Drug Design: a Graph Learning Perspective

Generative AI for graph-based drug design: Recent advances and the way forward

An Adaptive Graph Learning Method for Automated Molecular Interactions and Properties Predictions

Deep learning enhanced drug discovery for novel biomaterials in regenerative medicine utilizing graph neural network approach for predicting cellular responses

Visualizing Deep Graph Generative Models for Drug Discovery

De Novo Structure-Based Drug Design Using Deep Learning

De novo drug design using reinforcement learning with graph-based deep generative models

Generative chemistry: drug discovery with deep learning generative models

Could graph neural networks learn better molecular representation for drug discovery? A comparison study of descriptor-based and graph-based models

Relevant Applications of Generative Adversarial Networks in Drug Design and Discovery: Molecular De Novo Design, Dimensionality Reduction, and De Novo Peptide and Protein Design

CardiGraphormer: Unveiling the Power of Self-Supervised Learning in Revolutionizing Drug Discovery

Molecular Graph Generation via Geometric Scattering

Deep learning approaches for <i>de novo</i> drug design: An overview

Network-principled deep generative models for designing drug combinations as graph sets